Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.3763
+0.02597.39%
Post-market: 0.3761-0.0002-0.05%19:30 EDT
Volume:128.46K
Turnover:47.28K
Market Cap:14.21M
PE:-0.86
High:0.3900
Open:0.3630
Low:0.3512
Close:0.3504
52wk High:1.98
52wk Low:0.2500
Shares:37.77M
Float Shares:25.85M
Volume Ratio:0.24
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4366
EPS(LYR):-0.4366
ROE:-2174.98%
ROA:-247.30%
PB:-9.11
PE(LYR):-0.86

Loading ...

Aug 14, 2023

Correspondence

Form CORRESP - Correspondence
Jul 21, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Apr 05, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 22, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 15, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 14, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Dec 06, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 10, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers